Practical articles organized by catalog use, documentation review, custom planning, and research procurement.
Choose a category to narrow the published guidance.
14 articles
B-500 is a 7-amino-acid synthetic fragment of thymosin beta-4, with a molecular weight only one-sixth of the full protein. This article explains its structure, design logic, and potential limitations.
Read guidance →
The law looks at intended use, not at the label. If the marketing, dosing guidance, and customer emails all point at human use, the product is an unapproved drug. This article explains why the "research use only" label does not hold up in court or before regulators.
Read guidance →
There is no validated dosing protocol for CJC-1295 + Ipamorelin. This article reviews trial doses, common community protocols, and the full reconstitution math table.
Read guidance →
GLOW’s reputation comes from the individual evidence of its three peptides, but the blend itself has no research. This article reviews the human evidence grades for GHK-Cu, BPC-157, and TB-500, and the only animal study combining two of them.
Read guidance →
Cagrilintide has an unusually complete human dataset for an unapproved peptide: REDEFINE 1 enrolled 3,417 people, REDEFINE 2 enrolled 1,206 with type 2 diabetes, and REIMAGINE 2 enrolled 2,713. This article walks through the weight-loss, HbA1c and adverse-event data trial by trial, and flags which results are not yet formally published.
Read guidance →
There is a clear gap between Retatrutide trial dosing and community practice. This article reviews Phase II and III titration schedules, common community doses, and why “no validated protocol” is itself important information.
Read guidance →
TB-500 is often equated with thymosin beta-4, but they are chemically different. This article explains the difference, TB-500’s actin regulation mechanism, and why many online claims actually come from thymosin beta-4 research.
Read guidance →
The relationship between BPC-157 and inflammation is one of the most discussed topics among users. This article explains what users report, what animal research has found, and why the claim of "reducing inflammation" should be treated with caution.
Read guidance →
How Are Peptides Made Inside Cells? From DNA transcription and ribosomal translation to Kozak sequence positioning, secretory vesicles, and exocytosis, this article walks through every step of peptide production in a single complete pathway.
Read guidance →
A collaborative study by Duke University and Eli Lilly found that tirzepatide stimulates insulin secretion in human pancreatic islets through dual GLP-1R and GIPR activation, with GIPR activity being essential. This confirms it is not merely a "super GLP-1" but a true dual agonist, pointing to a new direction for multi-target anti-obesity drugs.
Read guidance →
A practical checklist for identifying a catalog record and giving the review team enough information to answer accurately.
Read guidance →
Understand the difference between a catalog statement, a mapped historical file, and documentation for the material currently being quoted.
Read guidance →
The sequence, modification, purity, quantity, analytical, destination, and timing details that make a custom request reviewable.
Read guidance →
A controlled way to compare identity, specification, evidence, destination requirements, and lead time before a purchase decision.
Read guidance →